Peer Review History
| Original SubmissionSeptember 9, 2025 |
|---|
|
Junco hyemalis Dear Dr. Amaya-Mejia, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please submit your revised manuscript by Dec 06 2025 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org . When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.
If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols . Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols . We look forward to receiving your revised manuscript. Kind regards, Angela Monica Ionica, Ph.D. Academic Editor PLOS ONE Journal Requirements: When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf 2. We note that the grant information you provided in the ‘Funding Information’ and ‘Financial Disclosure’ sections do not match. When you resubmit, please ensure that you provide the correct grant numbers for the awards you received for your study in the ‘Funding Information’ section. 3. Please expand the acronym “UCLA” (as indicated in your financial disclosure) so that it states the name of your funders in full. This information should be included in your cover letter; we will change the online submission form on your behalf. 4. We noted in your submission details that a portion of your manuscript may have been presented or published elsewhere. [Yes, a version of this manuscript is a part of WAM's doctoral dissertation and will need to be published on ProQuest as part of the graduation requirements.] Please clarify whether this publication was peer-reviewed and formally published. If this work was previously peer-reviewed and published, in the cover letter please provide the reason that this work does not constitute dual publication and should be included in the current manuscript. 5. When completing the data availability statement of the submission form, you indicated that you will make your data available on acceptance. We strongly recommend all authors decide on a data sharing plan before acceptance, as the process can be lengthy and hold up publication timelines. Please note that, though access restrictions are acceptable now, your entire data will need to be made freely accessible if your manuscript is accepted for publication. This policy applies to all data except where public deposition would breach compliance with the protocol approved by your research ethics board. If you are unable to adhere to our open data policy, please kindly revise your statement to explain your reasoning and we will seek the editor's input on an exemption. Please be assured that, once you have provided your new statement, the assessment of your exemption will not hold up the peer review process. 6. Please note that PLOS One has specific guidelines on code sharing for submissions in which author-generated code underpins the findings in the manuscript. In these cases, we expect all author-generated code to be made available without restrictions upon publication of the work. Please review our guidelines at https://journals.plos.org/plosone/s/materials-and-software-sharing#loc-sharing-code and ensure that your code is shared in a way that follows best practice and facilitates reproducibility and reuse. 7. To comply with PLOS ONE submissions requirements, in your Methods section, please provide additional information regarding the experiments involving animals and ensure you have included details on methods of anesthesia and/or analgesia. If the reviewer comments include a recommendation to cite specific previously published works, please review and evaluate these publications to determine whether they are relevant and should be cited. There is no requirement to cite these works unless the editor has indicated otherwise. Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? Reviewer #1: Yes Reviewer #2: Yes ********** 2. Has the statistical analysis been performed appropriately and rigorously? -->?> Reviewer #1: Yes Reviewer #2: Yes ********** 3. Have the authors made all data underlying the findings in their manuscript fully available??> The PLOS Data policy Reviewer #1: Yes Reviewer #2: Yes ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English??> Reviewer #1: Yes Reviewer #2: Yes ********** Reviewer #1: Summary: This study by Amaya-Mejia and colleagues describes the alteration of gut microbiota in Juncos birds affected by Plasmodium. This paper is describing changes in microbiome associated to the infection, to discuss two main hypothesis about the link between dysbiosis and parasitic infection. This study is well written, well conducted and very clear. It was a pleasure to read it, and I have no major comments. My only minor suggestions concern the text, and I expect no supplementary experiment. Although clear, the Results section often lacks an interpretation or a comment after the key results. I made some suggestions hereafter. The introduction presents the challenge of the definition of dysbiosis, but the discussion lacks a follow-up to this introduction. Please find hereafter my comments. Abstract: Line 19 : please rephrase the beginning of the sentence “For beta diversity, while infected birds had different bacteria than non-infected birds” as it is unclear Line 28: the statement “However, in addition to the observed reduced microbial diversity, dysbiosis requires a significant increase in pathogenic bacteria and reduction of beneficial bacteria.” is unclear Please use the same appellation for the birds between abstract and keywords, even if it refers to the same bird Introduction: Line 41 and later in the text: please either use the new names of Firmicutes (Bacillota) and Actinobacteria (Actinomycetes) or mention them Line 44-47: could you discuss here the hypothesis of “the parasitic infection is permitted by dysbiosis”? You reject this hypothesis in the discussion, but it seems to me that it is missing from the introduction. Line 48-50: can you add the notion of functions that are lost with dysbiosis? Can you add a word about the consequences for Juncos of the parasite infection? Are they strictly carrier/vectors, do they suffer from the infection? Last paragraph: not sure to follow how the different results would support one or the other hypothesis. This is clearer in the discussion part, notably with the “The hypothesis that gut microbiomes are altered due to Plasmodium infections is further supported by our co-occurrence networks that show significant dissimilarity between infected and non-infected birds, more than is expected by random chance.”, so please rephrase the introduction part to present more clearly how the results could support one or the other hypothesis. Methods: Could you provide the sequence of the primers used for the nested PCRs Results: The results section often lacks an interpretation or a comment after the key results. I made some suggestions hereafter. Could you comment the following results “Based on microscopy, parasitemia for these eight infected birds ranged from 0.1 – 0.7% infected RBC.” indicating if the values correspond to what is expected? Concerning body condition of the birds, could you explicit what is the body condition in terms of health for the bird? It would be clearer to me if you add a comment after the “Body condition, based on residuals of tarsus length and body mass, increased significantly with parasitemia” statement, to explicit the impact on the parasitemia on the bird health. If it’s relevant, you can also add a Figure showing the correlation. Discussion: The Discussion lacks a part about the definition of dysbiosis, and the limitation of using 16S sequencing compared to WGS. In the introduction, you discuss the definition of dysbiosis but never address it in the discussion. Moreover, the dysbiosis is a loss of microbial functions more than a decrease of diversity. The discussion is lacking this aspect, and this should be addressed in the limitations section as it is the main limitation of the study. Line 311: “While Firmicutes have also been reported to be depleted in infected birds, this was not observed in our study.” The Figure 2 seems to indicate a decrease in Firmicutes. There is no comment about this result in the Results section, so could you add something about the non-significant difference that you propose? In the Limitations section, please add a sentence about the fact that only males were used. Figures: Please either use the new names of Firmicutes (Bacillota) and Actinobacteria (Actinomycetes) or mention them Typos: Line 37: please remove the colon in the following sentence “In birds and other animals, these functions can include: nutritional uptake, detoxification, immune functions, and potentially serve to outcompete pathogenic microbes” to fit the syntax of the sentence Line 55: please remove the can “but these can may not capture subtle variations and can be subject to sampling bias” Line 57: please correct “it may be prudent to account for the relationships observed between bacteria, through co-occurrence networks” Line 145: please correct “DNA extractions were also used” Reviewer #2: Review report for manuscript entitled: Microbial community composition variation in response to malaria infections in Junco hyemalis This manuscript explores the relationship between Plasmodium relictum GRW04 infection and gut microbiota composition in Junco hyemalis. The topic is bridging ecology, parasitology, and microbiome research. The study presents an interesting preliminary dataset and contributes to a growing understanding of parasite–microbiome interactions in wild avian systems. The comments below are intended to support the authors in improving clarity, methodological robustness, and interpretative depth. Major comments - Sample size justification The study includes only 16 individuals (8 infected, 8 uninfected). Authors mentioned that this sample size is similar to other used in animal studies. However, this requires at least some sort of statistical justification. Authors acknowledge this limitation in the discussion, these results should be explicitly presented as exploratory. Suggestion: Reframe all inferential language (e.g., “infection altered the microbiota”) to correlative phrasing (“infection status was associated with variation in…”). - Use of microbiome instead of microbiota. In this study authors performed amplicon sequencing using 16S hypervariable regions V3-V4. Microbiota is the adequate word. - Ambiguous causal interpretation between parasitemia and microbiome variation Since all infections appear chronic and low intensity, microbiome variation might predate infection or reflect host condition rather than infection per se. Suggestion: Rephrase interpretations to reflect association rather than causation. If possible, include parasitemia as a continuous covariate in multivariate analyses (rather than binary infection status) to test for dose-dependent effects. - Framing and reporting inconsistencies Reporting of statistical results is also inconsistent (some analyses lack test names or exact p-values). Suggestion: • Temper causal phrasing throughout (e.g., replace “infection caused dysbiosis” with “infection status was associated with variation of microbiota composition”). • Provide full statistical reporting (test name, statistic, exact p-value) for all analyses. Minor Comments 1. Abstract: o Lines 22–23: Consider adding: rare bacterial taxa. o Lines 24–26: The discussion of hypotheses may be better placed in the Discussion section rather than in the Abstract. 2. Introduction o Baseline microbiome composition of Junco hyemalis. The introduction would benefit from a short paragraph summarizing known Junco or closely related passerine gut microbiome profiles. o Ensure all bacterial phyla names are italicized throughout the manuscript. o Line 52-54: extensive methodological details for introduction section. Consider removing. o Line 55: Rephrase for clarity “but these can may not capture subtle variations…” o 3. Methods o Line 132–133: The phrase “Blood smears were periodically stained (within 30 days)” suggests repeated staining. Please clarify whether staining occurred once per sample and specify the time between fixation and staining. o Line 145–148: Replace the second repeated phrase “nested PCR approach” with “This technique.” o PCR protocol description: it is more useful, for reproducibility purpose, to report concentrations of the elements included rather than volumes. Please also include the exact number of cycles both PCR rounds. o There is no mention of verifying DNA concentration or purity for blood samples prior to nested PCR amplification. o Line 150: Replace “H20” with “H₂O” (letter O, not zero). o Use the proper microliter symbol “µL” in all instances. o Only define abbreviations the first time they appear on the text. o Consider adding a brief paragraph outlining the Sanger sequencing protocol (e.g., cleanup, sequencing platform, read quality verification). o Line 156–157: Reword for clarity o Line 168: Provide the evaporation temperature and duration during DNA concentration. o The manuscript authors refer to “low parasitemia” but does not specify parasitemia scale defining low vs high infection. o Line 174: already mentioned in data availability section no need to mention it here. 4. Results o Line 205: how many individuals were screened in total ? o Table 1: Move the explanatory text (“Parasitemia is based on...”) to the table footnote. o Table 1: Replace “0/1” infection status code with “No detectable / Detectable” for clarity. o Table1: Does banding date corresponds with sample collection date? If so could be useful to have a column of DNA extraction date. o Confirm whether banding date corresponds to the date of sample collection and, if relevant, add a column indicating DNA extraction date. o Figure 2b: Replace “bacteria” with “phyla” in the legend. o Consider visualizing the ANCOM-BC results in a volcano plot. The following paper might help: Maust et al. (DOI: https://doi.org/10.1016/j.heliyon.2023.e22145) o Figure 3: The legend should mention the type of ordination used (e.g., PCoA) and the percentage of variance explained on each axis. Please revise the legend. o Line 225: ASV abbreviation redefined. o Line 240: Plasmidium relictum is not italicized. 5. Discussion o State whether non-Plasmodium-infected birds were screened for other pathogens that could confound microbiota results. ********** what does this mean? ). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy Reviewer #1: No Reviewer #2: No ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] To ensure your figures meet our technical requirements, please review our figure guidelines: https://journals.plos.org/plosone/s/figures You may also use PLOS’s free figure tool, NAAS, to help you prepare publication quality figures: https://journals.plos.org/plosone/s/figures#loc-tools-for-figure-preparation. NAAS will assess whether your figures meet our technical requirements by comparing each figure against our figure specifications.
|
| Revision 1 |
|
Microbial community composition variation in relation to malaria infections in Junco hyemalis PONE-D-25-49187R1 Dear Dr. Amaya-Mejia, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice will be generated when your article is formally accepted. Please note, if your institution has a publishing partnership with PLOS and your article meets the relevant criteria, all or part of your publication costs will be covered. Please make sure your user information is up-to-date by logging into Editorial Manager at Editorial Manager® and clicking the ‘Update My Information' link at the top of the page. For questions related to billing, please contact billing support . If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Angela Monica Ionica, Ph.D. Academic Editor PLOS One Additional Editor Comments (optional): Reviewers' comments: Reviewer's Responses to Questions Comments to the Author Reviewer #1: All comments have been addressed Reviewer #2: All comments have been addressed ********** 2. Is the manuscript technically sound, and do the data support the conclusions??> Reviewer #1: Yes Reviewer #2: Yes ********** 3. Has the statistical analysis been performed appropriately and rigorously? -->?> Reviewer #1: Yes Reviewer #2: Yes ********** 4. Have the authors made all data underlying the findings in their manuscript fully available??> The PLOS Data policy Reviewer #1: Yes Reviewer #2: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English??> Reviewer #1: Yes Reviewer #2: Yes ********** Reviewer #1: (No Response) Reviewer #2: Authors addressed all suggested comments. The manuscript is clear and concise with sufficient methodological detail to be reproduced by the scientific community. I have no further recommendations. ********** what does this mean? ). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy Reviewer #1: No Reviewer #2: No ********** |
| Formally Accepted |
|
PONE-D-25-49187R1 PLOS One Dear Dr. Amaya-Mejia, I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS One. Congratulations! Your manuscript is now being handed over to our production team. At this stage, our production department will prepare your paper for publication. This includes ensuring the following: * All references, tables, and figures are properly cited * All relevant supporting information is included in the manuscript submission, * There are no issues that prevent the paper from being properly typeset You will receive further instructions from the production team, including instructions on how to review your proof when it is ready. Please keep in mind that we are working through a large volume of accepted articles, so please give us a few days to review your paper and let you know the next and final steps. Lastly, if your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. You will receive an invoice from PLOS for your publication fee after your manuscript has reached the completed accept phase. If you receive an email requesting payment before acceptance or for any other service, this may be a phishing scheme. Learn how to identify phishing emails and protect your accounts at https://explore.plos.org/phishing. If we can help with anything else, please email us at customercare@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. Angela Monica Ionica Academic Editor PLOS On |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .